Activation of the Lectin Pathway
Mechanism of Activation
The lectin pathway is primarily activated by the binding of pattern recognition molecules, specifically mannose-binding lectin (MBL) or ficolins, to carbohydrate structures on pathogen surfaces. 1, 2
The lectin pathway represents one of the three major activation pathways of the complement system, alongside the classical and alternative pathways. Its activation involves several key steps:
Primary Activators
Pattern Recognition Molecules:
- Mannose-binding lectin (MBL)
- Ficolins (L-ficolin, H-ficolin, and M-ficolin in humans)
- These molecules recognize specific carbohydrate patterns arranged in particular geometries on microbial surfaces 1
Target Structures:
- Mannose, N-acetylglucosamine, and other carbohydrates on pathogen surfaces
- These carbohydrates are typically arranged in patterns that are not found on healthy human cells 2
Activation Process
Recognition Phase:
- MBL or ficolins bind to carbohydrate structures on pathogen surfaces
- These pattern recognition molecules are complexed with MBL-associated serine proteases (MASPs) in circulation 3
Protease Activation:
- Upon binding to pathogens, conformational changes occur in the MBL/ficolin-MASP complex
- This leads to autoactivation of the associated serine proteases 1
Complement Cascade Initiation:
Key Components
Pattern Recognition Molecules
- MBL: Contains collagen-like domains and carbohydrate recognition domains (CRDs)
- Ficolins: Contain collagen-like domains and fibrinogen-like domains that recognize acetylated compounds 3
MBL-Associated Serine Proteases
- MASP-1: Activates MASP-2 and cleaves C2
- MASP-2: Primary enzyme responsible for C4 and C2 cleavage
- MASP-3: Role in lectin pathway unclear, but involved in alternative pathway
- MAp44 and sMAP: Truncated forms of MASPs with regulatory functions 1
Regulation of Activation
The lectin pathway is tightly regulated to prevent excessive activation and potential tissue damage:
- C1-inhibitor (C1-inh): Major physiological inhibitor of MASP-1 and MASP-2
- Antithrombin (AT): Effectively inhibits MASPs, especially in the presence of heparin
- α2-macroglobulin: Forms complexes with MASP-1 but does not effectively inhibit the lectin pathway on activator surfaces 5
Clinical Significance
- Innate Immunity: The lectin pathway serves as a first-line defense against pathogens before adaptive immunity is engaged
- Deficiencies: Deficiencies in components of the lectin pathway are associated with increased susceptibility to infections 1
- Complement Activation: In conditions like sepsis, the lectin pathway can be activated by microbes, contributing to the inflammatory response 6
- Hereditary Angioedema: C1-inhibitor deficiency affects regulation of the lectin pathway, contributing to disease pathophysiology 6
Evolutionary Perspective
The lectin pathway represents an ancient immune mechanism:
- Present in invertebrates and vertebrates
- Predates the evolution of adaptive immunity
- Consists of lectin-protease complexes that function in an opsonic manner in primitive organisms 4
Understanding the activation mechanisms of the lectin pathway is crucial for developing therapeutic approaches targeting complement-mediated diseases and for comprehending the body's response to various pathogens.